Thermo Fisher Scientific, a provider in serving science, signed a definitive agreement to acquire Ahura Scientific, a supplier of field-deployed analytical instruments for human health and public safety, for US$145 million in cash plus the potential for an earn-out payment based on the achievement of certain 2010 financial targets. Ahura's products expand Thermo's portfolio of portable analytical devices designed to provide customers with the ability to rapidly identify and authenticate a range of molecular and elemental substances in the field. Based in Wilmington, Massachusetts, Ahura Scientific has approximately 120 employees and generated full-year revenue of approximately $45 million in 2009.
Thermo Fisher Scientific, a provider in serving science, signed a definitive agreement to acquire Ahura Scientific, a supplier of field-deployed analytical instruments for human health and public safety, for US$145 million in cash plus the potential for an earn-out payment based on the achievement of certain 2010 financial targets. Ahura's products expand Thermo's portfolio of portable analytical devices designed to provide customers with the ability to rapidly identify and authenticate a range of molecular and elemental substances in the field. Based in Wilmington, Massachusetts, Ahura Scientific has approximately 120 employees and generated full-year revenue of approximately $45 million in 2009.
Ahura specializes in the identification of chemicals for safety, security and pharmaceutical applications. The company's rugged, miniaturized Raman and Fourier-transform IR spectroscopy instruments are used worldwide by military and civilian first responders, major pharmaceutical manufacturers and consumer health organizations. Ahura products complement the Thermo line of portable X-ray fluorescence elemental analyzers, which are designed for rapid on-site testing of materials for numerous applications, including metal and alloy analysis, quality assurance and control, consumer product safety and environmental analysis.
"The acquisition of Ahura further enhances our position in handheld analyzers and strengthens our Thermo brand by expanding the breadth of our portfolio with complementary technologies," said Marc Casper, President and CEO of Thermo Fisher Scientific. "It also provides the ability to leverage our commercial channel, product development expertise and software over multiple laboratory and portable instrument platforms. This combination brings together both companies' technologies for portable chemical and elemental analysis, allowing us to create a powerful tool set for our customers that enables laboratory-quality analysis in the field."
The transaction, which is expected to close during the first quarter of 2010, is subject to applicable regulatory approvals and a customary post-closing purchase price adjustment. Ahura will be integrated into Thermo's analytical technologies segment. The company does not expect this transaction to have a material impact on its 2010 financial results.